Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate COVID 19 Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04800120
What this trial is testing

Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress

Who this might be right for
Covid19
Steward St. Elizabeth's Medical Center of Boston, Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT04896606
What this trial is testing

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Who this might be right for
Covid19
New York Medical College 50
Testing effectiveness (Phase 2)Study completedNCT04780321
What this trial is testing

JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects

Who this might be right for
COVID-19
Shanghai Junshi Bioscience Co., Ltd. 62
Not applicableUnknownNCT05374772
What this trial is testing

A Retrospective Study in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shanghai Pudong Hospital 300
Not applicableStudy completedNCT06695377
What this trial is testing

Thromboembolic Complications in Mild Covid-19 Cases

Who this might be right for
COVID 19Thromboembolic and Bleeding ComplicationsThromboembolism, Venous+1 more
Marmara University Pendik Training and Research Hospital 961
Not applicableStudy completedNCT04384380
What this trial is testing

Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

Who this might be right for
Coronavirus Infection
Taoyuan General Hospital 33
Not applicableUnknownNCT04643054
What this trial is testing

Efficacy and Safety of Ovotransferrin in COVID-19 Patients

Who this might be right for
Covid19
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 100
Testing effectiveness (Phase 2)Ended earlyNCT04880109
What this trial is testing

APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.

Who this might be right for
COVID-19
Aptabio Therapeutics, Inc. 16
Large-scale testing (Phase 3)Study completedNCT04494204
What this trial is testing

Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients

Who this might be right for
Treatment of Covid-19 Virus Infection
PUNEET MITTAL 100
Testing effectiveness (Phase 2)Study completedNCT05164120
What this trial is testing

Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19

Who this might be right for
COVID-19
MedStar Health 40
Testing effectiveness (Phase 2)UnknownNCT06288893
What this trial is testing

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

Who this might be right for
COVID-19
JKT Biopharma Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT05616728
What this trial is testing

Evaluate EDP-235 in Non-hospitalized Adults With COVID-19

Who this might be right for
COVID-19
Enanta Pharmaceuticals, Inc 231
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Large-scale testing (Phase 3)UnknownNCT05675072
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Who this might be right for
Mild to Moderate COVID-19
Frontier Biotechnologies Inc. 1,336
Testing effectiveness (Phase 2)Ended earlyNCT05172141
What this trial is testing

A Safety, Tolerability, and Efficacy Study of IBI314 in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Innovent Biologics (Suzhou) Co. Ltd. 222
Testing effectiveness (Phase 2)Study completedNCT04676867
What this trial is testing

Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19

Who this might be right for
Covid19
DalCor Pharmaceuticals 227
Large-scale testing (Phase 3)Ended earlyNCT04869228
What this trial is testing

Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male Patients

Who this might be right for
COVID-19
Suzhou Kintor Pharmaceutical Inc, 380
Testing effectiveness (Phase 2)Ended earlyNCT04305457
What this trial is testing

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19

Who this might be right for
Coronavirus InfectionsPneumonia, ViralAcute Respiratory Distress Syndrome
Massachusetts General Hospital 62
Testing effectiveness (Phase 2)Study completedNCT04701658
What this trial is testing

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Eli Lilly and Company 109
Large-scale testing (Phase 3)Study completedNCT05506176
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Jiangsu Simcere Pharmaceutical Co., Ltd. 1,208
Next Page